196 related articles for article (PubMed ID: 31512706)
21. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.
Vyas D; Lopez-Hisijos N; Gandhi S; El-Dakdouki M; Basson MD; Walsh MF; Huang X; Vyas AK; Chaturvedi LS
J Nanosci Nanotechnol; 2015 Sep; 15(9):6413-22. PubMed ID: 26690867
[TBL] [Abstract][Full Text] [Related]
23. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
Lee R; Choi YJ; Jeong MS; Park YI; Motoyama K; Kim MW; Kwon SH; Choi JH
Bioconjug Chem; 2020 Mar; 31(3):923-932. PubMed ID: 32027493
[TBL] [Abstract][Full Text] [Related]
25. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q
Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
27. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
Wang X; Gu X; Wang H; Yang J; Mao S
Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
[TBL] [Abstract][Full Text] [Related]
28. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
[TBL] [Abstract][Full Text] [Related]
29. Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery.
Bae Y; Kim Y; Lee ES
Molecules; 2021 Jun; 26(12):. PubMed ID: 34200716
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line.
Akbarzadeh A; Samiei M; Joo SW; Anzaby M; Hanifehpour Y; Nasrabadi HT; Davaran S
J Nanobiotechnology; 2012 Dec; 10():46. PubMed ID: 23244711
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
33. Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment.
Zhang X; Zhao M; Cao N; Qin W; Zhao M; Wu J; Lin D
Biomater Sci; 2020 Mar; 8(7):1885-1896. PubMed ID: 32022813
[TBL] [Abstract][Full Text] [Related]
34. Glutamic acid-coated Fe
Dutta B; Nema A; Shetake NG; Gupta J; Barick KC; Lawande MA; Pandey BN; Priyadarsini IK; Hassan PA
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110915. PubMed ID: 32409067
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.
Liu D; Zhang Q; Wang J; Fan L; Zhu W; Cai D
Pharmazie; 2019 Feb; 74(2):83-90. PubMed ID: 30782256
[TBL] [Abstract][Full Text] [Related]
36. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
[TBL] [Abstract][Full Text] [Related]
37. Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin.
Li M; Yue X; Wang Y; Zhang J; Kan L; Jing Z
J Mater Chem B; 2019 Dec; 7(47):7619-7626. PubMed ID: 31746936
[TBL] [Abstract][Full Text] [Related]
38. LDH-stabilized ultrasmall iron oxide nanoparticles as a platform for hyaluronidase-promoted MR imaging and chemotherapy of tumors.
Zhang N; Wang Y; Zhang C; Fan Y; Li D; Cao X; Xia J; Shi X; Guo R
Theranostics; 2020; 10(6):2791-2802. PubMed ID: 32194835
[TBL] [Abstract][Full Text] [Related]
39. Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization.
Rangasami VK; Samanta S; Parihar VS; Asawa K; Zhu K; Varghese OP; Teramura Y; Nilsson B; Hilborn J; Harris RA; Oommen OP
Carbohydr Polym; 2021 Feb; 254():117291. PubMed ID: 33357860
[TBL] [Abstract][Full Text] [Related]
40. A multi-controlled drug delivery system based on magnetic mesoporous Fe
Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
